VENLAFAXIN: 20 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
20
Total FAERS Reports
1 (5.0%)
Deaths Reported
11
Hospitalizations
20
As Primary/Secondary Suspect
4
Life-Threatening
1
Disabilities
First Report: 20090813 · Latest Report: 20140213
What Are the Most Common VENLAFAXIN Side Effects?
#1 Most Reported
Hyponatraemia
3 reports (15.0%)
#2 Most Reported
Hepatic enzyme increased
3 reports (15.0%)
#3 Most Reported
General physical health deterioration
3 reports (15.0%)
All VENLAFAXIN Side Effects by Frequency
No side effect data available.
Who Reports VENLAFAXIN Side Effects? Age & Gender Data
Average age: 43.2 years. Most reports from: DE. View detailed demographics →
Is VENLAFAXIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 0 |
| 2013 | 6 | 0 | 6 |
| 2014 | 7 | 0 | 4 |
What Is VENLAFAXIN Used For?
| Indication | Reports |
|---|---|
| Depression | 9 |
Official FDA Label for VENLAFAXIN
Official prescribing information from the FDA-approved drug label.